More infrastructure spending, a focus on product innovation and efficient cost management are encouraging for the Zacks ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported ...

Create a no-code AI researcher with two research modes and verifiable links, so you get quick answers and deeper findings ...